South Korea
· Delayed Price · Currency is KRW Bukwang Pharmaceutical Statistics
Total Valuation
KRX:003000 has a market cap or net worth of KRW 388.74 billion. The enterprise value is 251.83 billion.
| Market Cap | 388.74B |
| Enterprise Value | 251.83B |
Important Dates
The next estimated earnings date is Monday, March 16, 2026.
| Earnings Date | Mar 16, 2026 |
| Ex-Dividend Date | Nov 4, 2025 |
Share Statistics
KRX:003000 has 98.66 million shares outstanding. The number of shares has increased by 9.11% in one year.
| Current Share Class | 98.66M |
| Shares Outstanding | 98.66M |
| Shares Change (YoY) | +9.11% |
| Shares Change (QoQ) | +597.40% |
| Owned by Insiders (%) | 14.01% |
| Owned by Institutions (%) | 3.36% |
| Float | 67.95M |
Valuation Ratios
The trailing PE ratio is 30.17.
| PE Ratio | 30.17 |
| Forward PE | n/a |
| PS Ratio | 2.11 |
| PB Ratio | 1.14 |
| P/TBV Ratio | 1.17 |
| P/FCF Ratio | 22.88 |
| P/OCF Ratio | 17.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.53, with an EV/FCF ratio of 14.82.
| EV / Earnings | 25.87 |
| EV / Sales | 1.37 |
| EV / EBITDA | 19.53 |
| EV / EBIT | 32.84 |
| EV / FCF | 14.82 |
Financial Position
The company has a current ratio of 4.60, with a Debt / Equity ratio of 0.24.
| Current Ratio | 4.60 |
| Quick Ratio | 3.71 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 6.09 |
| Debt / FCF | 4.72 |
| Interest Coverage | 1.23 |
Financial Efficiency
Return on equity (ROE) is 3.36% and return on invested capital (ROIC) is 1.36%.
| Return on Equity (ROE) | 3.36% |
| Return on Assets (ROA) | 1.21% |
| Return on Invested Capital (ROIC) | 1.36% |
| Return on Capital Employed (ROCE) | 1.96% |
| Revenue Per Employee | 299.81M |
| Profits Per Employee | 15.83M |
| Employee Count | 615 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.10 |
Taxes
| Income Tax | -8.27B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.72% in the last 52 weeks. The beta is 0.71, so KRX:003000's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | -14.72% |
| 50-Day Moving Average | 3,738.80 |
| 200-Day Moving Average | 3,871.55 |
| Relative Strength Index (RSI) | 56.55 |
| Average Volume (20 Days) | 532,923 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:003000 had revenue of KRW 184.38 billion and earned 9.74 billion in profits. Earnings per share was 130.59.
| Revenue | 184.38B |
| Gross Profit | 80.19B |
| Operating Income | 7.96B |
| Pretax Income | 1.30B |
| Net Income | 9.74B |
| EBITDA | 13.18B |
| EBIT | 7.96B |
| Earnings Per Share (EPS) | 130.59 |
Balance Sheet
The company has 217.55 billion in cash and 80.26 billion in debt, giving a net cash position of 137.29 billion or 1,391.47 per share.
| Cash & Cash Equivalents | 217.55B |
| Total Debt | 80.26B |
| Net Cash | 137.29B |
| Net Cash Per Share | 1,391.47 |
| Equity (Book Value) | 340.83B |
| Book Value Per Share | 2,446.75 |
| Working Capital | 239.47B |
Cash Flow
In the last 12 months, operating cash flow was 22.56 billion and capital expenditures -5.57 billion, giving a free cash flow of 16.99 billion.
| Operating Cash Flow | 22.56B |
| Capital Expenditures | -5.57B |
| Free Cash Flow | 16.99B |
| FCF Per Share | 172.20 |
Margins
Gross margin is 43.49%, with operating and profit margins of 4.32% and 5.28%.
| Gross Margin | 43.49% |
| Operating Margin | 4.32% |
| Pretax Margin | 0.71% |
| Profit Margin | 5.28% |
| EBITDA Margin | 7.15% |
| EBIT Margin | 4.32% |
| FCF Margin | 9.21% |
Dividends & Yields
This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 1.27%.
| Dividend Per Share | 50.00 |
| Dividend Yield | 1.27% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 38.29% |
| Buyback Yield | -9.11% |
| Shareholder Yield | -7.85% |
| Earnings Yield | 2.50% |
| FCF Yield | 4.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.1.
| Last Split Date | Dec 29, 2020 |
| Split Type | Forward |
| Split Ratio | 1.1 |
Scores
KRX:003000 has an Altman Z-Score of 2.97 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.97 |
| Piotroski F-Score | 7 |